|
Tocilizumab at emerging CRS Clinical Trials
1 actively recruiting trial
Also known as: On demand
Pipeline
Phase 2: 1
Top Sponsors
- Insel Gruppe AG, University Hospital Bern1
Indications
- Myeloma1
- Leukemia1
- Lymphoma1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.